According to IMARC Group’s report, titled “Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025”, the global multiple sclerosis therapies market experienced moderate growth during 2014-2019. Looking forward, IMARC Group expects the global market to continue its moderate growth by 2025.
Multiple sclerosis (MS) is a severe inflammatory immune-mediated condition that may cause axonal transection, demyelination and neurodegeneration of the nerve cells in the brain and spinal cord. Some of the commonly used therapies to treat MS include oral and infused medicines, administration of injectables, antidepressants, muscle relaxants and physical therapy. Multiple sclerosis therapies help in managing the symptoms to reduce the frequency of the relapses and control the heart rate and blood pressure of the patient.
The growing prevalence of primary-progressive multiple sclerosis, secondary-progressive multiple sclerosis, and progressive-relapsing multiple sclerosis across the globe is primarily driving the demand for MS therapies. Furthermore, the increasing geriatric population, who are more prone to multiple sclerosis, is also providing a thrust to the market. Besides this, the healthcare providers are widely utilizing immunosuppressants that control autoimmune attacks and lower relapses among patients suffering from multiple sclerosis. Additionally, numerous technological advancements, such as the development of innovative monoclonal bodies, immunosuppressants, immunomodulators, and interferons for the effective treatment of multiple sclerosis, are further augmenting the market growth. Moreover, governments of several countries are launching campaigns to spread awareness regarding the available treatment alternatives among the masses, which is expected to further propel the market in the coming years.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Get a PDF sample for more detailed market insights: https://www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsa...
Global Multiple Sclerosis Therapies Market Competitive Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the multiple sclerosis therapies market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Bristol-Myers Squibb Company
Abbvie Inc.
GlaxoSmithKline Plc
Merck & Co. Inc.
Hoffmann-La Roche AG (Roche Holding AG)
Bayer Aktiengesellschaft
Novartis AG
Biogen Inc.
Sanofi S.A. and Teva Pharmaceutical Industries Ltd.
The report has segmented the global multiple sclerosis therapies market on the basis of drug, drug type, route of administration, distribution channel and region.
Breakup by Drug:
Immunomodulators
Copaxone
Avonex/Plegridy
Gilneya
Tysabri
Betaseron/Extavia
Tecifidera
Rebif
Ampyra
Immunosuppressants
Aubagio
Lemtrada
Ocrelizumab
Zinbryta
Breakup by Drug Type:
Biologic Drugs
Small Molecule Drugs
Breakup by Route of Administration:
Oral
Injectable
Intravenous
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Breakup by Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Explore full report with table of contents: https://www.imarcgroup.com/multiple-sclerosis-therapies-market
Key highlights of the report:
Market Performance (2014-2019)
Market Outlook (2020-2025)
Market Drivers and Success Factors
Industry Trends
The Impact of COVID-19 on the Global Market
Value Chain Analysis
Structure of the Global Market
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Cardiac Resynchronization Therapy (CRT) Market: https://www.imarcgroup.com/cardiac-resynchronization-therapy-market
Osteoarthritis Therapeutics Market Report: https://www.imarcgroup.com/osteoarthritis-therapeutics-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
America: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800